Preparation and Evaluation of Mouse Premature Ovarian Insufficiency Model
Authors:
- 19 September 2025
- journal article
- video audio-media
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 223,p. e69000
Abstract
Premature ovarian insufficiency (POI) is a critical condition leading to female infertility, necessitating reliable animal models for mechanistic and therapeutic research. Here, we present a standardized protocol for establishing and evaluating a cyclophosphamide (CTX)-induced POI mouse model. Six-to-eight-week-old female mice with regular estrous cycles were selected and subjected to intraperitoneal CTX injections: an initial dose of 100 mg/kg on day 1, followed by daily doses of 20 mg/kg for the subsequent 14 days. Dynamic changes in estrous cycles were monitored via vaginal smear cytology with Wright staining. Serum levels of estradiol (E2), follicle-stimulating hormone (FSH), and anti-Müllerian hormone (AMH) were quantified using ELISA to assess endocrine alterations. Ovarian histopathology was evaluated through hematoxylin-eosin (H&E) staining of paraffin-embedded sections to quantify follicular atresia, while immunohistochemical analysis of cleaved caspase-3 was performed to detect granulosa cell apoptosis. Results demonstrated disrupted estrous cyclicity, significantly reduced E2 and AMH levels, elevated FSH concentrations, increased follicular atresia, and enhanced granulosa cell apoptosis in CTX-treated mice, confirming successful POI modeling. This model-building method can highly mimic the mechanism of chemotherapy-induced ovarian damage, presenting typical pathological features such as follicle reserve depletion and sex hormone disorders. It provides a reliable experimental platform for revealing the reproductive toxicity mechanism of chemotherapy, screening ovarian-protecting drugs, and optimizing fertility preservation strategies. Moreover, this model is relatively simple to operate, low-cost, and has a short production cycle, making it easy to carry out and popularize. The methodology aligns with the requirements of JoVE for visualizable, step-by-step experimental demonstrations.Keywords
This publication has 13 references indexed in Scilit:
- Bushen Huoxue recipe ameliorates ovarian function via promoting BMSCs proliferation and homing to ovaries in POI micePhytomedicine, 2024
- Transplantation of the LRP1high subpopulation of human umbilical cord-derived mesenchymal stem cells improves ovarian function in mice with premature ovarian failure and aged miceStem Cell Research & Therapy, 2024
- Protective effect of Luffa cylindrica fermentation liquid on cyclophosphamide-induced premature ovarian failure in female mice by attenuating oxidative stress, inflammation and apoptosisJournal of Ovarian Research, 2024
- Tamoxifen decreases ovarian toxicity without compromising cancer treatment in a rat model of mammary cancerBMC Genomics, 2023
- Adipose-derived stem cells promote the repair of chemotherapy-induced premature ovarian failure by inhibiting granulosa cells apoptosis and senescenceStem Cell Research & Therapy, 2023
- Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic reviewHuman Reproduction Update, 2022
- Staging of the estrous cycle and induction of estrus in experimental rodents: an updateFertility Research and Practice, 2020
- Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertilityCell Death & Disease, 2019
- Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in miceStem Cell Research & Therapy, 2017
- Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancerCancer, 2011